Therapeutics & Vaccines
Gene Editing-Based Method Of Attenuating The Beta-Amyloid Pathway
WARF: P170275US02
Inventors: Subhojit Roy, Jichao Sun
The Invention
Described herein are CRISPR/Cas9 constructs designed for the C-terminal truncation of human amyloid precursor protein (APP) as well as methods of making and using such a construct.
Tech Fields
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847